Save your place

Sign in to WhoBought

Please try again later.

Jim Simons's CorMedix Inc. (CRMD) position

Not anymore: Jim Simons fully exited CRMD in Q3 2025. The position peaked at $1.9M in Q2 2025.
View full portfolio →
Value at exit
$1.9M
Shares at exit
152K
Est. average buy price (i)
$11.04
Quarter-end price
$12.32

Estimated trade prices

Average price in quarters with purchases
$6.40
Average prices in quarters with sales
  • Q2 2024: $5.08 (78K shares sold)

CRMD price vs Simons's position

1Y 3Y 5Y MAX
Dates
$3$10$15$20202420252026New position of 107K shares · Q3 2023. Average closing price $3.98 · Price range $3.60–$4.46107KsharespurchasedAdded 129K shares (121.1%) · Q4 2023. Average closing price $3.44 · Price range $3.00–$4.01129KsharespurchasedAdded 3K shares (1.3%) · Q1 2024. Average closing price $3.47 · Price range $2.94–$4.243KsharespurchasedSold 78K shares (32.7%) · Q2 2024. Average closing price $5.08 · Price range $4.08–$6.3978KsharessoldNew position of 134K shares · Q4 2024. Average closing price $9.99 · Price range $8.10–$13.59134KsharespurchasedNew position of 152K shares · Q2 2025. Average closing price $11.04 · Price range $5.86–$16.56152Ksharespurchased← Earlier —5 purchases
Average closing price · filing quarter
$11.04
Price range · filing quarter
$5.86 – $16.56
Sign in to see who bought

Every quarterly change

Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Q3 2025 Exited −152K −$1.8M −100.0% 0 Nov 13, 2025
Q2 2025 New +152K +$1.7M – 152K Aug 13, 2025
Q4 2024 New +134K +$1.3M – 134K Feb 13, 2025
Q2 2024 Reduced −78K −$396K −32.7% 161K Aug 9, 2024
Q1 2024 Added +3K +$10K +1.3% 239K May 13, 2024
Q4 2023 Added +129K +$444K +121.1% 236K Feb 13, 2024
Q3 2023 New +107K +$424K – 107K Nov 14, 2023
Q1 2023 Added +108K +$442K +146.9% 182K May 12, 2023
Q4 2022 Added +60K +$212K +441.2% 74K Feb 13, 2023
Q3 2022 New +14K +$57K – 14K Nov 14, 2022
Q1 2022 New +10K +$47K – 10K May 13, 2022
Q3 2021 New +118K +$687K – 118K Nov 12, 2021
Data through Q3 2025 · filed Nov 13, 2025
12 grouped rows from 12 quarters

More Simons positions

United Therapeutics Corporation(UTHR)
$1.1B
1.7% of portfolio

Palantir Technologies Inc.(PLTR)
$997M
1.6% of portfolio

Apple Inc.(AAPL)
$778M
1.2% of portfolio

Kinross Gold Corporation(KGC)
$780M
1.2% of portfolio

Micron Technology, Inc.(MU)
$731M
1.1% of portfolio

VeriSign, Inc.(VRSN)
$700M
1.1% of portfolio

Common questions

Does Jim Simons own CRMD?

Not currently. Jim Simons fully exited CRMD in Q3 2025, and the complete history is above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Jim Simons buy CRMD?

Jim Simons first disclosed a CRMD position in Q3 2021; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Jim Simons sell CRMD?

Yes. Jim Simons reduced and then fully exited CRMD by Q3 2025; the reductions are in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of CRMD does Jim Simons own?

None as of the latest filing: Jim Simons has exited CRMD. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Jim Simons pay for CRMD?

Jim Simons's estimated average buy price for CRMD is $11.04, from quarter-average prices weighted by the shares added each quarter. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.